Type 2 & other diabetes

Insulin resistance in adipose tissue and fatty liver, but not fat mass, are involved in worsening glycaemic status: The Hiroshima study on glucose metabolism and cardiovascular diseases

Diabetes Obes MetabPublished Observational cohort study

Authors' conclusion

Adipose tissue insulin resistance, rather than fat mass, is crucial in all stages of deterioration of glycaemic status. Fatty liver plays a decisive role in the eventual development of type 2 diabetes.

Study context

Population
Individuals who underwent two 75-g OGTTs at baseline and follow-up (Hiroshima study on glucose metabolism and CVD)
Participants
3,644 individuals
Exposure
Highest vs lowest quartiles of Adipo-IR, lipid accumulation product (LAP) and fatty liver index (FLI)
Outcome
Progression from normoglycaemia to prediabetes and from prediabetes to T2D
Follow-up
mean 2.9-year follow-up
Methodological detailslongitudinal, two 75-g OGTTs at baseline and follow-up
  • Longitudinal
  • Two 75-g OGTTs at baseline and follow-up

Main finding

As reported in the abstract

Progression of impaired glucose metabolism by Adipo-IR quartile
Highest quartile vs Lowest quartileOdds ratio (95% CI)
Baseline Adipo-IR; normoglycaemia to prediabetes
2.22(1.36–3.65)
Change in Adipo-IR; normoglycaemia to prediabetes
2.70(1.83–3.98)
Baseline Adipo-IR; prediabetes to T2D
2.02(1.04–3.92)
Change in Adipo-IR; prediabetes to T2D
3.09(1.84–4.19)
Progressed from normoglycaemia to prediabetes
463 (32.4%)
Developed T2D from prediabetes
198 (10.6%)

Observational data: associations, not effects.

Further findings

FLI

Changes in FLI were associated with progression from prediabetes to T2D

LAP

LAP did not affect progression of impaired glucose metabolism

Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.

Original publication

Insulin resistance in adipose tissue and fatty liver, but not fat mass, are involved in worsening glycaemic status: The Hiroshima study on glucose metabolism and cardiovascular diseases. Diabetes Obes Metab. Published 5 March 2025. doi:10.1111/dom.16307

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.